Tejnaksh Healthcare Ltd.

29.91 +0.14 ▲0.5%

23 February 2024, 04:01:00 PM
Volume: 30,116

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.tejnaksh.com
Market Cap 60.80 Cr.
Enterprise Value(EV) 62.25 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.62 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 48.56 Trailing Twelve Months Ending 2023-12
Industry PE 71.22 Trailing Twelve Months Ending 2023-12
Book Value / Share 11.35 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.64 Calculated using Price: 29.93
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 2.03 Cr. 20,313,600 Shares
FaceValue 5
About Tejnaksh Healthcare Ltd.
The company is an integrated healthcare delivery service provider, committed to delivering quality healthcare services to its patients in modern facilities. Its operations are divided across four key vertical streams in healthcare delivery, namely - “Pediatric Urology”, “Adult Urology (Male, Female)”, “Andrology and Sexual Dysfunction” and “Nephrology, Dialysis and Renal Transplant”. It offers a gamut of more than 65 healthcare services under these streams. A base of over 65 employees and consultants supports its healthcare facility network. The company's healthcare facilities use advanced technology and its doctors, nurses and other healthcare professionals follow treatment protocols that match international standards. A majority of its healthcare facilities provide secondary, tertiary and quaternary healthcare services to patients. Some of its healthcare facilities provide super speciality quaternary healthcare to patients in key specialty areas such as Pediatric Urology and Adult Urology (Male, Female).

Tejnaksh Healthcare Ltd. Delivery

Delivered Qty
Traded Qty

Tejnaksh Healthcare Ltd. Performance

1 Day
+0.47%
1 Week
+1.25%
1 Month
-1.22%
3 Month
-5.56%
6 Month
-11.93%
1 Year
-32.91%
2 Year
-59.43%
5 Year
+13.94%
10 Year

Tejnaksh Healthcare Ltd. Fundamental Ratios

8 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 21.17 26.68 34.98 26.93 15.1 12.71 15.05 8.57
Return on Capital Employed (%) 34 29.35 32.66 27.59 17.78 14.2 17.22 11.36
Return on Assets (%) 19.32 16.96 17.97 14.93 9.1 8.36 10.38 5.89

Tejnaksh Healthcare Ltd. Balance Sheet

Particulars 9 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 6 8 10 13 15 17 20 22 23
Non Curr. Liab. 0 7 6 6 7 5 7 7 7
Curr. Liab. 0 1 3 2 2 2 2 2 2
Minority Int. 0 0 0 0 0 1 1 1
Equity & Liab. 7 16 20 22 25 25 30 31 32
Non Curr. Assets 6 14 17 18 18 21 25 25 25
Curr. Assets 1 2 3 5 7 3 5 6 6
Misc. Exp. not W/O
Total Assets 7 16 20 22 25 25 30 31 32

Tejnaksh Healthcare Ltd. Profit and Loss

Particulars 9 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 5 7 14 20 17 12 13 12 12
Other Income 0 0 0 2 0 0 0 0 0
Total Income 5 7 15 21 17 12 13 12 12
Total Expenditure -2 -4 -9 -16 -13 -8 -8 -8 -9
PBIDT 2 3 6 6 4 4 5 4 3
Interest 0 -1 -1 -1 -1 0 -1 -1
Depreciation 0 0 0 -1 -1 -1 -1 -1 -1
Taxation -1 -1 -1 -1 -1 -1 -1 -1 -1
Exceptional Items
PAT 1 2 3 3 2 2 3 2 1
Minority Interest 0 0 0 0 0 0 0
Share Associate 0
Other Related Items
Consolidated Net Profit 1 2 3 3 2 2 3 2 1
Adjusted EPS 1 1 1 1 1 1 1 1 1

Tejnaksh Healthcare Ltd. Cash Flow

Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 4 2 4 3 1 1 9 2
Cash Fr. Inv. -3 -8 -3 -2 -1 2 -11 -1
Cash Fr. Finan. 0 6 -1 -2 0 -3 2 -1
Net Change 0 1 1 -1 0 0 0 0
Cash & Cash Eqvt 0 1 2 1 1 1 1 1

Tejnaksh Healthcare Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 73.83 73.83 73.83 73.83 73.83 73.83 73.83 73.83 73.83
Public 26.17 26.17 26.17 26.17 26.17 26.17 26.17 26.17 26.17
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Tejnaksh Healthcare Ltd. Announcements

Mon, 12 Feb 2024
Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The QuarterEnded On 31St December 2023.
Please Find Attached Result
Mon, 12 Feb 2024
Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And DisclosureRequirements) Regulations 2015
In continuation of our Letter dated 5th February 2024 we wish to inform you that a meeting of theBoard of Directors of the Company was held on Monday 12th February 2024 at A 601 Floor No.6 Kailash Business Park Veer Savarkar Marg Vikroli - West Mumbai - 400079 at 5.30 p.m. and hastransacted the following: -1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for thequarter ended on 31st December 2023 and took note of Limited Review Report thereon in termsof Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015;The meeting of Board of Directors commenced at 5.30 p.m. and concluded at 9.30 pm
Mon, 05 Feb 2024
Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015 And ClosureOf Trading Window
Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Monday 12TH February 2024 at A 601 Floor No.6 Kailash Business Park Veer Savarkar Marg Vikroli - West Mumbai - 400079 to transact the business as given below:1. To Consider and approve Un-Audited Financial Results (Gtandalone & Consolidated) for theQuarter Ended on 31st December 2023.2. Any other matter with the permission of the Chair.

Tejnaksh Healthcare Ltd. Technical Scans

Fri, 23 Feb 2024
High Decrease in 1 Year High Decrease in 1 Year
High Decrease in 2 Years High Decrease in 2 Years
5 SMA Crossing 20 SMA From Below 5 SMA Crossing 20 SMA From Below
Closing Near 20 SMA Closing Near 20 SMA
Close Crossing 20 SMA From Below Close Crossing 20 SMA From Below

Tejnaksh Healthcare Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 374,572.18 1,560.95 +0.2%
Cipla Ltd. 118,375.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. 107,511.08 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. 97,345.81 6,742.15 -0.4%
Divi's Laboratories Ltd. 96,748.70 3,636.05 -0.3%
Zydus Lifesciences Ltd. 93,335.34 922.10 +1.9%
Torrent Pharmaceuticals Ltd. 88,913.00 2,627.10 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.06 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 31.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.56 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.33 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 69.96 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.39 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.51 2,627.10 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.00 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 4.57 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.42 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.80 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.43 2,627.10 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,627.10 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,627.10 +0.7%

Tejnaksh Healthcare Ltd. FAQ's

What is Tejnaksh Healthcare share price?

Can I buy Tejnaksh Healthcare shares now?

What is the Market Cap of Tejnaksh Healthcare?

What are the key metrics to analyse Tejnaksh Healthcare?

What is the 52 Week High and Low of Tejnaksh Healthcare?

What is the trend of Tejnaksh Healthcare share price?